📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
96 announcements match the current filters (relevance ≥ 5).
Mold-Tek Packaging Approves 1:1 Bonus Issue and Recommends ₹3/Share Final Dividend
Mold-Tek Packaging's Board has approved a 1:1 bonus issue (1 equity share of ₹5 for every 1 share held), issuing 3,32,28,914 shares by capitalizing ₹16.61 crore from available free reserves of ₹655.12 crore. The Board also recommended a final dividend of ₹3 per share (60% on FV of ₹5) for FY26. To accommodate the bonus issue, the authorized share capital is being doubled from ₹20 crore to ₹40 crore, subject to shareholder approval at the AGM on September 21, 2026.
Confidence: HIGH
What changedThe Board approved a 1:1 bonus equity issue, a ₹3/share final dividend, an increase in authorized capital to ₹40 crore, and appointed Mr. Rana Pratap Janumahanti as Whole-Time Director.
Why it mattersThe 1:1 bonus doubles the paid-up share count to 6.65 crore shares to improve trading liquidity without altering underlying business fundamentals or cash reserves significantly.
Bonus Ratio: 1:1Bonus Shares to Issue: 3,32,28,914Free Reserves Capitalized: ₹16.61 CrAvailable Free Reserves: ₹655.12 CrFinal Dividend: ₹3 per share (60%)Post-Bonus Paid-up Capital: ₹33.23 Cr
📅 Short termLikely positive market sentiment around the 1:1 bonus announcement and dividend reward; stock will adjust ex-bonus around the eventual record date.
📈 Long termLimited operational impact; the bonus restructuring enhances stock liquidity while the dividend reflects ongoing cash generation.
⚠ Risk flags
- Subject to shareholder approval at the upcoming AGM on September 21, 2026
Key Highlights
Approved 1:1 bonus share issue (1 share of ₹5 for every 1 share held)
Capitalization of ₹16.61 Cr from free reserves/retained earnings (₹655.12 Cr available as of March 31, 2026)
Recommended FY26 final dividend of ₹3 per equity share (60% of FV ₹5)
Doubled authorized share capital from ₹20 Cr (4 Cr shares) to ₹40 Cr (8 Cr shares)
Bonus shares estimated to be credited/dispatched within 2 months of board approval
👀 What to Watch
Track voting outcomes at the 29th AGM scheduled for September 21, 2026, and watch for subsequent intimations regarding the record dates for dividend and bonus entitlements.
12x YoY Profit Jump in Q1 FY27; Civil Order Book Grows to $4.4 Million
Mold-Tek Technologies reported a sharp recovery in Q1 FY27, with net profit jumping 12x YoY and 4x QoQ, driven by cost rationalization in the Mechanical Engineering Services (MES) division and strong Civil engineering demand. The Civil order book reached $4.4 million (approx. ₹37 Cr), representing ~20% of TTM revenue, up from $2.7 million last year. Management is pivoting the MES division toward data center power distribution and expects the Beryl acquisition to turn profitable by Q3 FY27 as design work is offshored to India. The company is targeting $5.5 million in revenue from Beryl for the full year with an 8% EBITDA margin.
Confidence: HIGH
What changedThe company has stabilized its Beryl acquisition at break-even and successfully downsized its underperforming automotive MES segment to focus on higher-growth infrastructure sectors.
Why it mattersThis represents a turnaround from FY25's margin compression, leveraging India-based design talent to service U.S. residential and infrastructure markets, which should structurally improve operating margins.
Civil Order Book: $4.4 millionMES Order Book: $1.15 millionBeryl FY Revenue Target: $5.5 millionBeryl EBITDA Margin Target: 8%YoY Profit Growth: 12x
📅 Short termThe market is likely to react positively to the significant profit recovery and the robust growth in the civil order book reported in the transcript.
📈 Long termStructural margin improvement is expected as the company shifts from low-margin automotive work to high-demand data center infrastructure and offshores U.S. design work to India.
⚠ Risk flags
- U.S. interest rate sensitivity affecting residential permits
- Execution risk in scaling the India design team
- U.S. government funding volatility
Key Highlights
Net profit increased 12x YoY and 4x QoQ in Q1 FY27 due to operational efficiencies.
Civil engineering order book grew to $4.4 million, a 63% increase from $2.7 million in the previous year.
Beryl acquisition targeted to reach $5.5 million revenue in FY27 with 8% EBITDA margins.
India-based design team for Beryl expanded to 7 members to capture cost arbitrage from U.S. operations.
MES division downsizing in the automotive sector helped significantly reduce software and employee costs.
👀 What to Watch
Watch for the successful transition of Beryl's design work to the India team and the execution of the new power distribution contract for data centers, which are key to sustaining the margin recovery.
Rs 6.00 Cr PAT: Anmol India Reports 139% Sequential Profit Growth in Q1 FY27
Anmol India Limited reported a net profit of Rs 6.00 Cr for the quarter ended June 30, 2026, marking a sharp 139% recovery from Rs 2.51 Cr in the previous quarter. Revenue from operations reached Rs 455.72 Cr, growing 47.7% sequentially, though it remains 21% lower than the Rs 577.36 Cr reported in the same quarter last year. The company's EPS improved to Rs 1.05 from Rs 0.44 in the preceding quarter. Despite the growth, finance costs remain high at Rs 4.34 Cr, consuming a significant portion of operating profits.
Confidence: HIGH
What changedThe company has reported a strong sequential recovery in both top-line and bottom-line performance for the first quarter of the new fiscal year.
Why it mattersFor a micro-cap trading company with thin margins (1.3% OPM), the jump in quarterly profit to Rs 6.00 Cr is significant, potentially improving its low P/E valuation of 5.2 if sustained.
Net Profit (Q1 FY27): Rs 6.00 CrRevenue (Q1 FY27): Rs 455.72 CrQ1 Revenue vs TTM Revenue: 32.15%EPS (Basic): Rs 1.05Finance Costs: Rs 4.34 Cr
📅 Short termThe stock may see positive sentiment in the short term due to the strong sequential earnings beat and improved EPS.
📈 Long termLong-term sustainability depends on the company's successful diversification into high-value commodities like Iron and Steel to offset the volatility and thin margins of the thermal coal trading business.
⚠ Risk flags
- High Debt-to-Equity ratio of 1.66
- High finance costs relative to profit
- Thin operating margins (1.3%) typical of trading businesses
Key Highlights
Net Profit grew 139% sequentially to Rs 6.00 Cr from Rs 2.51 Cr in March 2026.
Revenue from operations stood at Rs 455.72 Cr, representing 32.1% of the total TTM revenue.
Earnings Per Share (EPS) increased to Rs 1.05 for Q1 FY27 compared to Rs 1.01 in Q1 FY26.
Finance costs decreased slightly to Rs 4.34 Cr from Rs 4.89 Cr in the year-ago period.
Total Comprehensive Income for the period reached Rs 6.00 Cr, up from Rs 5.72 Cr YoY.
👀 What to Watch
Investors should monitor the company's ability to maintain these improved margins across the next two quarters and watch for any reduction in debt, as finance costs currently impact over 50% of the profit before tax.
Q1 PAT Surges to ₹10.03 Cr; $1M Order Win and $4.5M Work-on-Hand Reported
Mold-Tek Technologies reported a robust Q1 FY27 with standalone revenue growing 56.3% YoY to ₹45.52 Cr. Standalone PAT saw a massive jump to ₹10.03 Cr from ₹0.59 Cr in the same quarter last year, driven by the successful integration of Beryl Project Engineering. The company's Work-on-Hand (WOH) increased to $4.50 million, and its subsidiary Beryl secured a $1 million Master Purchase Order from Hillsburg County. Expansion into Forsyth County, Georgia, marks the beginning of geographic diversification beyond Florida.
Confidence: HIGH
What changedThe company has successfully integrated the Beryl acquisition, leading to a significant jump in profitability and a expanded service portfolio in the US residential market.
Why it mattersThe shift towards high-margin regulatory engineering and building inspections in the US is significantly improving the company's bottom line and reducing its dependence on traditional structural detailing.
Q1 Standalone Revenue: ₹45.52 CrQ1 Standalone PAT: ₹10.03 CrWork-on-Hand: $4.50 millionNew Order Value (Hillsburg): $1 millionWOH vs TTM Revenue: ~20.7%
📅 Short termThe stock is likely to react positively to the sharp increase in quarterly profits and the announcement of a fresh $1 million order.
📈 Long termThe expansion into 3,000+ US counties and the shift toward integrated engineering solutions provide a structural growth runway if execution remains consistent.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Sensitivity to US interest rates affecting the construction sector
- Geographic concentration in Florida (though currently diversifying)
- Dependency on skilled engineering talent
Key Highlights
Standalone Revenue increased 56.3% YoY to ₹45.52 Cr in Q1 FY27.
Standalone PAT jumped to ₹10.03 Cr compared to ₹0.59 Cr in Q1 FY26.
Work-on-Hand (WOH) grew by $1 million during the quarter to reach $4.50 million.
Secured a $1 million Master Purchase Order from Hillsburg County, expected to impact Q2 revenues.
Standalone EPS for the quarter rose to ₹3.48 from ₹0.20 in the previous year's corresponding quarter.
👀 What to Watch
Investors should monitor the execution of the $1 million Hillsburg order in Q2 and the margin sustainability as the company expands into Georgia. The transition from structural detailing to higher-value permit and inspection services is the key driver to watch.
1600% YoY PAT Growth; Q1 Revenue up 56% to Rs 45.52 Cr; USD 4.5M Order Book
Mold-Tek Technologies reported a massive turnaround in Q1 FY27, with standalone PAT surging to Rs 10.03 Cr from just Rs 0.59 Cr in the same quarter last year. Standalone revenue grew 56.3% YoY to Rs 45.52 Cr, driven by the successful integration of Beryl Project Engineering and growth in Civil & Structural services. The company's Work-on-Hand (WOH) increased to USD 4.50 million, providing strong revenue visibility for the upcoming quarters. Additionally, a significant USD 1 million Master Purchase Order was secured from Hillsburg County, and the company has initiated expansion into Georgia, USA.
Confidence: HIGH
What changedSignificant jump in quarterly profitability and revenue following the successful integration of the Beryl acquisition and expansion in the US market.
Why it mattersThis validates the company's strategy of moving into high-margin US regulatory and residential engineering services, significantly reducing dependence on the cyclical automotive segment.
Q1 Standalone Revenue: Rs 45.52 CrQ1 Standalone PAT: Rs 10.03 CrWork-on-Hand: USD 4.50 millionHillsburg County Order: USD 1 millionWOH vs TTM Revenue: ~20.8%
📅 Short termThe stock is likely to react very positively to the extreme earnings surprise, as the quarterly profit alone is nearly equal to the previous full year's profit.
📈 Long termThe structural shift towards US-based regulatory engineering and an integrated onshore-offshore model could lead to a long-term re-rating if growth in the USD 400B+ US engineering market continues.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Slowdown in US construction due to interest rates
- Dependency on highly skilled engineering talent
Key Highlights
Standalone Revenue grew 56.3% YoY to Rs 45.52 Cr in Q1 FY27
Standalone PAT increased over 16-fold to Rs 10.03 Cr from Rs 0.59 Cr in the previous year's quarter
Work-on-Hand (WOH) reached USD 4.50 million, up from USD 3.50 million in the previous quarter
Secured a USD 1 million Master Purchase Order from Hillsburg County for residential and permit engineering
Quarterly Standalone EPS of Rs 3.48 nearly matches the entire TTM EPS of Rs 3.51
👀 What to Watch
Investors should monitor the sustainability of these high margins as the company expands into Georgia and the conversion rate of the USD 4.5 million order book into realized revenue.
280% YoY PAT Growth in Q1 FY27; TiO2 Operations Remain Suspended Due to 8-10x Input Cost Surge
Meghmani Organics Limited (MOL) reported a significant recovery in profitability for Q1 FY27, with consolidated PAT surging 280% YoY to ₹48.2 Cr, despite a 12% decline in revenue to ₹542 Cr. The margin expansion to 18% (from 10.9% YoY) was driven by a disciplined pricing strategy and improved product mix in the Crop Protection segment, which maintained a 19.9% EBITDA margin. However, the Pigment segment continues to face low utilization at 39%, and the Titanium Dioxide (TiO2) plant remains suspended as raw material (sulfur) prices spiked from ₹4-5 to ₹35-40. Consolidated debt stands at ₹732 Cr with a manageable debt-to-equity ratio of 0.46.
Confidence: HIGH
What changedThe company has successfully pivoted to a margin-protection strategy, achieving an 18% EBITDA margin despite a 12% drop in top-line revenue caused by global demand headwinds.
Why it mattersThe sharp recovery in PAT and margins indicates strong operational control in the core Crop Protection business, though the idle TiO2 asset and low Pigment utilization remain significant drags on overall asset turnover.
Q1 Consolidated Revenue: ₹542 CrQ1 PAT Growth (YoY): 280%Consolidated EBITDA Margin: 18%Crop Protection EBITDA Margin: 19.9%Consolidated Debt-to-Equity: 0.46Q1 Revenue vs TTM Revenue: ~25%
📅 Short termThe market is likely to react positively to the substantial margin expansion and bottom-line growth, despite the revenue contraction.
📈 Long termLong-term value depends on the commercial viability of the TiO2 plant and the successful market penetration of the new Nano-fertilizer portfolio.
⚠ Risk flags
- Suspended TiO2 operations due to unviable raw material costs
- Low capacity utilization (39%) in the Pigment segment
- High sensitivity to global sulfur prices
Key Highlights
Consolidated PAT increased 280% YoY to ₹48.2 Cr despite revenue falling 12% to ₹542 Cr.
Crop Protection segment utilization reached 63%, contributing 75% of total revenue with a 19.9% EBITDA margin.
Pigment segment utilization remains low at 39%, with management targeting ₹550-600 Cr annual revenue.
Titanium Dioxide (TiO2) operations are suspended due to sulfur prices increasing 8-10x (from ₹4-5 to ₹35-40).
Total consolidated debt stood at ₹732 Cr as of June 30, 2026, with ₹32 Cr repaid during the quarter.
👀 What to Watch
Watch for the volume ramp-up in the Nano Urea and Nano DAP segments, which are expected to be key growth drivers, and monitor global sulfur price trends for any potential restart of the TiO2 facility.
Rs 300 Cr+ Quarterly Revenue; EBITDA/kg Hits Record Rs 46.7 in Q1 FY27
Mold-Tek Packaging reported a record quarterly turnover exceeding Rs 300 Cr, driven by high-margin segments and raw material price pass-throughs. EBITDA per kg reached a historical high of Rs 46.7, significantly above the typical Rs 40-42 range, aided by the consolidation of Hyderabad manufacturing units from five to two. While volume growth was tempered at 6% due to a 17% decline in the lubricant segment caused by base oil supply issues, the Pharma and Food/FMCG segments showed strong momentum. Management expects to sustain an EBITDA per kg of Rs 44-45 for the full year FY27.
Confidence: HIGH
What changedThe company successfully consolidated five Hyderabad units into two and shifted its product mix toward higher-margin Pharma and Food/FMCG packaging.
Why it mattersThe record EBITDA per kg demonstrates structural margin improvement and the ability to pass through volatile raw material costs to customers.
Q1 Revenue: Rs 300 Cr+EBITDA per kg: Rs 46.7Lube Segment Volume Growth: -17%Q1 Capex: Rs 20-22 CrWorking Capital: Rs 125 CrPharma Sales Growth: 38%
📅 Short termThe record margin performance and revenue milestone are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe company is structurally diversifying away from decorative paints (aiming for 40% share in 3-4 years) toward high-growth Pharma and FMCG segments.
⚠ Risk flags
- Raw material price volatility
- Geopolitical risks affecting base oil supply for the lube segment
- High client concentration (top 10 customers = 60-70% revenue)
Key Highlights
Quarterly turnover crossed the Rs 300 Cr mark for the first time in the company's history.
EBITDA per kg reached a record Rs 46.7, up from the historical average of Rs 40-42.
Lube segment volumes declined by 17% due to base oil unavailability for private players amid geopolitical tensions.
Pharma segment sales grew 38% YoY, now contributing 3.5% to total sales value.
Invested Rs 20-22 Cr in capital expenditure during Q1 FY27.
👀 What to Watch
Watch for the volume ramp-up in the Food & FMCG segment and the sustainability of the Rs 45/kg EBITDA margin as raw material prices (PP copolymer) stabilize from recent peaks.
MOL Q1 Standalone PAT Rises 42% to ₹57.6 Cr; New Company Secretary Appointed
Meghmani Organics Limited (MOL) reported a 42.2% YoY increase in standalone net profit to ₹57.60 Cr for Q1 FY27, despite an 11.7% decline in revenue to ₹522.94 Cr. The profitability boost was primarily driven by a sharp 62.2% reduction in finance costs, which fell to ₹9.13 Cr from ₹24.13 Cr in the year-ago period. The company also appointed Mr. Naresh Prajapati as Company Secretary and Compliance Officer. Additionally, the amalgamation of two wholly-owned subsidiaries (Kilburn Chemicals and Meghmani Crop Nutrition) is underway with an appointed date of January 1, 2026.
Confidence: HIGH
What changedMOL reported its Q1 FY27 financial results and appointed a new Key Managerial Personnel (Company Secretary) following a board meeting on July 29, 2026.
Why it mattersThe significant reduction in finance costs and improved bottom line suggest better debt management or refinancing, which is critical given the current 0.30 D/E ratio and challenging pricing environment in agrochemicals.
Q1 FY27 Standalone PAT: ₹57.60 CrYoY PAT Growth: 42.2%Finance Cost Reduction: 62.2%Q1 Revenue vs TTM Revenue: ~24%Standalone EPS (Q1): ₹2.26
📅 Short termThe stock may react positively to the earnings beat on the profitability front and the substantial reduction in interest outgo.
📈 Long termLong-term value depends on the successful commercialization of the Multi-Purpose Plant (MPP) and Nano Urea facility to counter Chinese dumping and global price erosion.
⚠ Risk flags
- Global price erosion in agrochemicals
- Potential US tariffs impacting 22% of revenue
- Chinese manufacturers diverting excess capacity to India
Key Highlights
Standalone Net Profit grew 42.2% YoY to ₹57.60 Cr in Q1 FY27 from ₹40.51 Cr.
Finance costs decreased significantly by 62.2% to ₹9.13 Cr compared to ₹24.13 Cr in Q1 FY26.
Standalone Revenue from operations declined 11.7% YoY to ₹522.94 Cr from ₹592.60 Cr.
Mr. Naresh Prajapati, a Law Graduate with 10 years of experience, appointed as CS and Compliance Officer.
Proposed merger of Kilburn Chemicals and Meghmani Crop Nutrition into MOL is pending final regulatory effectiveness.
👀 What to Watch
Investors should monitor the volume ramp-up in the Titanium Dioxide (TiO2) and Nano Urea segments to offset global pricing pressures, and track the finalization of the subsidiary amalgamation for group structure simplification.
42% YoY PAT Growth to ₹57.6 Cr in Q1 FY27; EBITDA Margins Expand to 17.9%
Meghmani Organics (MOL) reported a strong bottom-line performance for Q1 FY27, with Net Profit rising 42% YoY to ₹57.6 crore despite a 12% YoY decline in revenue to ₹522.9 crore. The profitability surge was driven by better price realizations and a favorable product mix, which expanded EBITDA margins to 17.9% from 13.6% in the previous year. The Crop Protection segment remains the primary driver, contributing 75% of revenue with a healthy 19.9% EBITDA margin. However, the Pigment segment continues to face headwinds with low capacity utilization of 39%, and Titanium Dioxide (TiO2) operations remain suspended due to commercial unviability.
Confidence: HIGH
What changedMOL has shifted from a period of losses/low margins to significant profitability through better pricing and product mix, despite a contraction in overall revenue.
Why it mattersThe sharp recovery in margins suggests the company is successfully navigating global agrochemical headwinds, though the underutilization of the Pigment segment and the idle TiO2 asset remain drags on the return on capital.
Q1 FY27 Net Profit: ₹57.6 CrQ1 FY27 Revenue: ₹522.9 CrEBITDA Margin: 17.9%Q1 PAT vs TTM PAT: 198.6%Pigment Capacity Utilization: 39%Export Revenue Share: 85%
📅 Short termThe stock is likely to react positively to the substantial margin expansion and the fact that Q1 profit alone has surpassed the previous full year's TTM profit.
📈 Long termLong-term value depends on the successful scaling of the Nano Urea/fertilizer segment and improving the utilization of the Pigment and TiO2 assets which are currently underperforming.
⚠ Risk flags
- High export dependency (85%) makes the company vulnerable to global demand and currency fluctuations
- Suspended TiO2 operations represent an idle asset
- Low utilization in the Pigment segment
Key Highlights
Net Profit surged 42% YoY to ₹57.6 crore, significantly exceeding the TTM PAT of ₹29 crore.
EBITDA margins expanded by 430 basis points YoY to 17.9% due to improved product mix.
Crop Protection segment reported revenue of ₹391.6 crore with 63% capacity utilization.
Pigment segment revenue stood at ₹131.3 crore with a lower EBITDA margin of 12.1%.
Titanium Dioxide (TiO2) plant remains shut down following the withdrawal of anti-dumping duties and high raw material costs.
👀 What to Watch
Watch for the volume ramp-up of new Nano fertilizer products (Nano DAP, NPK, and Zinc) and any potential restart of the TiO2 plant if raw material prices stabilize or regulatory protection returns.
₹57.6 Cr Q1 PAT: Meghmani Organics Reports 42% YoY Profit Growth Despite Revenue Dip
Meghmani Organics (MOL) reported a standalone net profit of ₹57.60 Cr for Q1 FY27, a 42.2% increase from ₹40.51 Cr in the same quarter last year. While revenue from operations declined 11.8% YoY to ₹522.94 Cr, it showed a strong sequential recovery of 14.5% from Q4 FY26. A significant driver of the profit growth was a 62% reduction in finance costs, which fell to ₹9.13 Cr. The company is also progressing with the amalgamation of its wholly-owned subsidiaries to simplify its corporate structure.
Confidence: HIGH
What changedReported Q1 FY27 financial results showing a sharp turnaround in profitability and appointed Mr. Naresh Prajapati as the new Company Secretary.
Why it mattersThe substantial reduction in finance costs and sequential revenue growth suggest operational stabilization after a challenging FY24-25 marked by global price erosion and Chinese dumping.
Standalone Revenue (Q1): ₹522.94 CrStandalone PAT (Q1): ₹57.60 CrFinance Cost (Q1): ₹9.13 CrQ1 Revenue vs TTM Revenue: 24.1%Q1 PAT vs TTM PAT: 198.6%
📅 Short termThe stock is likely to react positively to the strong profit beat and the significant reduction in interest expenses.
📈 Long termStructural recovery depends on the successful integration of subsidiaries and the company's ability to gain market share in the Nano Urea segment to offset global agrochemical pricing pressures.
⚠ Risk flags
- Continued price erosion due to Chinese dumping
- Potential US tariffs impacting 22% of revenue
- Execution risk in the new Nano Urea segment
Key Highlights
Standalone Net Profit rose 42.2% YoY to ₹57.60 Cr from ₹40.51 Cr.
Finance costs significantly decreased to ₹9.13 Cr from ₹24.13 Cr in Q1 FY26.
Revenue from operations grew 14.5% sequentially to ₹522.94 Cr from ₹456.62 Cr in Q4 FY26.
Basic EPS for the quarter improved to ₹2.26 compared to ₹1.59 in the year-ago period.
👀 What to Watch
Monitor the completion of the subsidiary amalgamation (Kilburn Chemicals and Meghmani Crop Nutrition) and the volume ramp-up in the Nano Urea and TiO2 segments, which are critical for long-term revenue growth.
₹48.19 Cr Q1 Net Profit: Meghmani Organics Reports 280% YoY Profit Surge Despite Revenue Dip
Meghmani Organics (MOL) reported a consolidated net profit of ₹48.19 Cr for Q1 FY27, a 280% increase from ₹12.68 Cr in Q1 FY26, despite an 11.5% YoY decline in revenue to ₹542.83 Cr. The profitability boost was primarily driven by a 55.7% reduction in finance costs to ₹13.05 Cr and improved operational efficiencies. Sequentially, revenue grew 14.4% from ₹474.34 Cr in Q4 FY26, indicating a recovery in volumes. The company is also proceeding with the amalgamation of two wholly-owned subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, to simplify its corporate structure.
Confidence: HIGH
What changedMOL has demonstrated a sharp recovery in net margins and a significant reduction in interest outgo, alongside appointing a new Company Secretary, Mr. Naresh Prajapati.
Why it mattersThe substantial profit growth amid a challenging global environment (Chinese dumping and price erosion) suggests that internal cost controls and debt management are effectively shielding the bottom line.
Consolidated Revenue (Q1 FY27): ₹542.83 CrConsolidated Net Profit (Q1 FY27): ₹48.19 CrYoY Profit Growth: 280%Finance Costs (Q1 FY27): ₹13.05 CrStandalone EPS: ₹2.26Q1 Revenue vs TTM Revenue: 24.97%
📅 Short termThe stock is likely to react positively to the strong bottom-line beat and the sequential improvement in revenue compared to Q4 FY26.
📈 Long termLong-term sustainability depends on the successful scaling of the Nano Urea plant and the Multi-Purpose Plant (MPP) to diversify revenue away from commoditized pigments.
⚠ Risk flags
- Global price erosion in agrochemicals
- Chinese manufacturers diverting excess capacity to India
- Potential US tariffs impacting 22% of revenue share
Key Highlights
Consolidated Net Profit reached ₹48.19 Cr in Q1 FY27 vs ₹12.68 Cr in Q1 FY26.
Finance costs decreased significantly to ₹13.05 Cr from ₹29.47 Cr in the year-ago quarter.
Standalone Agrochemical segment revenue stood at ₹391.61 Cr with a segment profit of ₹70.06 Cr.
Standalone Pigment segment revenue was ₹131.33 Cr with a segment profit of ₹13.09 Cr.
Standalone EPS for the quarter improved to ₹2.26 compared to ₹1.59 in Q1 FY26.
👀 What to Watch
Investors should monitor the volume ramp-up in the Titanium Dioxide (TiO2) and Nano Urea segments, which are key to offsetting global pricing pressures. The upcoming amalgamation of subsidiaries should be watched for potential cost synergies and administrative streamlining.
25% Revenue Growth in Q1 FY27; Pharma Segment Volume Surges 39%
Mold-Tek Packaging reported a strong Q1 FY27 with revenue reaching ₹300.45 Cr, a 24.9% YoY increase. While total sales volume grew by a modest 6.25% to 12,089 MT, the company achieved a significant 12% improvement in EBITDA per kg to ₹46.68. This was driven by a strategic shift toward high-margin segments, with Pharma volumes growing 39% and Food/FMCG volumes growing 26% YoY. PAT increased 14.19% to ₹25.57 Cr, despite a 92 bps contraction in EBITDA margins due to higher material costs.
Confidence: HIGH
What changedThe company has successfully shifted its product mix toward higher-margin Pharma and Food packaging while consolidating its manufacturing footprint in Hyderabad for better cost control.
Why it mattersThe improvement in EBITDA per kg (₹46.68 vs ₹41.64) demonstrates pricing power and the success of premium In-Mold Labelling (IML) products, which helps insulate the company from volume volatility in traditional segments like Lubricants.
Revenue (Q1 FY27): ₹300.45 CrRevenue vs TTM Revenue: 40.6%EBITDA per KG: ₹46.68Pharma Volume Growth: 39%PAT (Q1 FY27): ₹25.57 CrInstalled Capacity: 66,900 TPA
📅 Short termThe stock is likely to react positively to the strong double-digit revenue and PAT growth, alongside the significant jump in high-margin Pharma volumes.
📈 Long termStructural expansion into Pharma and Food/FMCG packaging, combined with a capacity increase to nearly 67,000 TPA, positions the company for sustained earnings growth beyond its traditional paint and lubricant base.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High customer concentration (top 10 clients account for 60-70% of revenue)
- Raw material cost volatility (material costs rose 32% YoY)
- 17% volume decline in the Lubricants segment
Key Highlights
Revenue grew 24.9% YoY to ₹300.45 Cr, representing ~40.6% of the previous TTM revenue.
Pharma segment volume increased by 39% YoY to 263 MT, continuing its high-growth momentum.
EBITDA per KG improved by 12% to ₹46.68, reflecting better product mix and operational efficiency.
Consolidated 5 manufacturing units in Hyderabad into 2 locations to unlock EBITDA expansion.
Total sales volume reached 12,089 MT, up from 11,378 MT in the previous year's quarter.
👀 What to Watch
Monitor the capacity utilization at the new Panipat and Sultanpur (Pharma) units, as these are critical for maintaining the current high-margin growth trajectory. Watch for the impact of raw material price pass-through lags on margins in upcoming quarters.
Q1 Revenue crosses ₹300 Cr; EBITDA per kg hits record ₹46.68
Mold-Tek Packaging reported a strong Q1 FY27 with net sales growing 24.9% YoY to ₹300.45 cr, surpassing the ₹300 cr quarterly milestone. Profitability reached new heights with EBITDA per kg hitting a record ₹46.68, driven by a 38.75% volume surge in the high-margin Pharma segment. Despite geopolitical headwinds affecting the Lube segment, the company achieved 75% capacity utilization following the consolidation of five Hyderabad units into two. Net profit grew 14.15% YoY to ₹25.57 cr, supported by robust demand in Food & FMCG (+26.2% volume growth).
Confidence: HIGH
What changedQuarterly revenue crossed the ₹300 cr mark for the first time, and the company achieved record-high operational efficiency (EBITDA/kg) through unit consolidation and product mix optimization.
Why it mattersThe successful scaling of the Pharma and Food/FMCG segments is reducing the company's reliance on the cyclical Paint and Lube sectors, structurally improving margin profiles and asset utilization.
Q1 Net Sales: ₹300.45 crQ1 vs TTM Revenue: 40.6%EBITDA per kg: ₹46.68Pharma Volume Growth: 38.75%Capacity Utilization: 75%Installed Capacity: 63,000 TPA
📅 Short termThe stock is likely to react positively to the record EBITDA margins and the strong volume growth in high-margin segments despite geopolitical pressures.
📈 Long termThe transition from a commodity-linked packaging player to a specialized Pharma and FMCG packaging provider, backed by in-house robotics and IML technology, supports a long-term margin expansion thesis.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical risks impacting Lube segment demand
- High customer concentration (top 10 clients = 60-70% revenue)
- Raw material price volatility pass-through lag
Key Highlights
Net Sales increased 24.90% YoY to ₹300.45 cr, representing ~40.6% of the previous TTM revenue.
EBITDA per kg reached a historical high of ₹46.68, up from ₹41.64 in Q1 FY26.
Pharma segment volume grew by 38.75% YoY, with plans to expand into Ophthalmic-Packs and medical devices.
Consolidated 5 Hyderabad units into 2 major units (Annaram and Sultanpur) to reduce overheads and rejections.
Food & FMCG segment volume grew 26.20% YoY, supported by doubling production at the Panipat facility.
👀 What to Watch
Monitor the ramp-up of the Panipat facility and the execution of the entry into Ophthalmic-Packs and medical devices. Investors should also track if the record EBITDA margins are sustainable given the 1-3 month lag in passing through raw material cost changes.
Rs 300.45 Cr Revenue in Q1 FY27; EBITDA per kg hits record Rs 46.68
Mold-Tek Packaging reported a strong Q1 FY27 with revenue crossing the Rs 300 Cr milestone for the first time, a 24.9% YoY increase. Net profit grew 14.15% to Rs 25.57 Cr, supported by a record EBITDA of Rs 46.68 per kg, driven by operational consolidation and 75% capacity utilization. The high-margin Pharma segment showed robust volume growth of 38.75% YoY, while the company added several new clients in the Food and Pharma sectors. This quarterly revenue represents approximately 40.6% of the previous TTM revenue, indicating a significant scale-up in operations.
Confidence: HIGH
What changedThe company achieved record quarterly revenue and profitability margins (EBITDA/kg) through segment diversification and capacity expansion.
Why it mattersThe shift towards high-margin Pharma and Food/FMCG packaging reduces reliance on the cyclical paint and lubricant sectors, structurally improving the company's margin profile.
Revenue (Q1 FY27): Rs 300.45 CrPAT (Q1 FY27): Rs 25.57 CrEBITDA per kg: Rs 46.68Pharma Volume Growth: 38.75%Q1 Revenue vs TTM Revenue: 40.6%Installed Capacity: 63,000 TPA
📅 Short termThe stock is likely to react positively to the record EBITDA margins and the milestone of crossing Rs 300 Cr in quarterly revenue.
📈 Long termThe ongoing expansion into high-value pharmaceutical packaging and electronics/semiconductor packaging could lead to a structural re-rating if execution remains consistent.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High customer concentration (top 10 clients account for 60-70% of revenue)
- Raw material price volatility pass-through lag (1-3 months)
Key Highlights
Quarterly revenue crossed Rs 300 Cr for the first time, reaching Rs 300.45 Cr (up 24.9% YoY).
EBITDA per kg reached a historical high of Rs 46.68 due to improved capacity utilization.
Pharma segment volume grew by 38.75% YoY, with plans to enter Ophthalmic-Packs and medical devices.
Total sales volume increased 6.25% YoY to 12,089 MT.
Installed injection molding capacity expanded to over 63,000 TPA from 46,000 TPA in FY23.
👀 What to Watch
Monitor the ramp-up of the Panipat facility and the execution timeline for the new Ophthalmic-Packs and medical device verticals, which are expected to be high-margin drivers.
MOL Shareholders Approve Merger of Kilburn Chemicals and Meghmani Crop Nutrition
Meghmani Organics Limited (MOL) has received shareholder approval for the amalgamation of its two wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. The special resolution was passed with the requisite majority during an NCLT-convened meeting held on June 6, 2026. This consolidation is intended to streamline the corporate structure and enhance operational synergies. The voting results follow the NCLT order dated April 20, 2026, and the remote e-voting process conducted in early June.
Key Highlights
Special resolution passed for the amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition into MOL.
Both entities being merged are 100% wholly-owned subsidiaries of Meghmani Organics Limited.
Remote e-voting was conducted from June 3 to June 5, 2026, with the meeting concluded on June 6, 2026.
The merger process is being executed pursuant to the Hon’ble NCLT order dated April 20, 2026.
Consolidation is expected to simplify the group structure and reduce administrative overheads.
👀 What to Watch
Investors should view this consolidation as a positive step toward operational efficiency and corporate simplification; monitor for the final NCLT approval and the effective date of the merger.
Meghmani Organics Shareholders Approve Merger of Two Wholly Owned Subsidiaries
Shareholders of Meghmani Organics Limited (MOL) have approved a Special Resolution for the amalgamation of two wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. The voting was conducted via remote e-voting between June 3 and June 5, 2026, following an order from the Hon'ble NCLT. The resolution passed with the requisite majority, marking a significant step in the company's corporate restructuring process. This consolidation is intended to streamline operations and simplify the group structure.
Key Highlights
Special Resolution passed for the merger of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into MOL.
The amalgamation involves two 100% wholly-owned subsidiaries, simplifying the corporate structure.
Remote e-voting concluded on June 5, 2026, with the Scrutinizer's Report dated June 6, 2026.
The meeting was convened as per the Hon'ble NCLT order dated April 20, 2026.
The merger is expected to drive operational efficiencies and administrative synergies.
👀 What to Watch
Investors should monitor the final NCLT approval and the subsequent filing with the Registrar of Companies for the effective date of the merger. The consolidation is generally positive for long-term operational efficiency.
MOL Shareholders Approve Amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition
Shareholders of Meghmani Organics Limited (MOL) have approved the scheme of amalgamation for two wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. The special resolution was passed with the requisite majority during an NCLT-convened meeting held via remote e-voting between June 3 and June 5, 2026. This consolidation is intended to streamline the corporate structure and integrate the operations of these 100% owned entities.
Key Highlights
Special resolution for the merger of Kilburn Chemicals and Meghmani Crop Nutrition passed with requisite majority.
The meeting was conducted following the Hon'ble NCLT order dated April 20, 2026.
Remote e-voting facility was provided to members holding shares as of the cut-off date, May 30, 2026.
Both merging entities are 100% wholly-owned subsidiaries of Meghmani Organics Limited.
The amalgamation aims to simplify the group structure and enhance operational efficiencies.
👀 What to Watch
Investors should view this as a positive step toward corporate simplification; monitor the final NCLT approval and subsequent integration for potential cost synergies.
MOL Shareholders Approve Amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition
Shareholders of Meghmani Organics Limited (MOL) have approved the scheme of amalgamation for two of its wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. The approval was obtained via a Special Resolution during an NCLT-convened meeting held on June 06, 2026. The remote e-voting process, which took place from June 03 to June 05, 2026, saw the resolution passed with the requisite majority. This consolidation is expected to streamline the corporate structure and potentially improve operational efficiencies.
Key Highlights
Special Resolution passed for the merger of Kilburn Chemicals and Meghmani Crop Nutrition with MOL.
The meeting was conducted following the Hon’ble NCLT order dated April 20, 2026.
Remote e-voting was held between June 03, 2026, and June 05, 2026, for shareholders as of the May 30 cut-off.
Both merging entities are 100% wholly-owned subsidiaries of Meghmani Organics Limited.
The Scrutinizer’s Report dated June 06, 2026, confirmed the resolution was passed with the requisite majority.
👀 What to Watch
Investors should monitor the final NCLT approval and the subsequent integration process, as the consolidation of subsidiaries typically leads to better resource allocation and cost synergies.
Meghmani Organics Shareholders Approve Merger of Kilburn Chemicals and Meghmani Crop Nutrition
Meghmani Organics Limited (MOL) conducted an NCLT-convened meeting on June 6, 2026, to seek shareholder approval for the amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. The merger is designed to simplify the group structure into a single listed entity and achieve operational synergies through resource consolidation. The resolution was presented as a special resolution, and the final voting results are expected to be disclosed by June 9, 2026.
Key Highlights
Proposed amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition (wholly owned subsidiaries) with Meghmani Organics Limited.
The merger aims to eliminate duplicate compliances and rationalize costs by maintaining only one legal entity.
Meeting was chaired by NCLT-appointed Chairperson Dr. Ajar Rab and conducted via video conferencing.
The consolidation is expected to enhance operational agility and unlock long-term value through a single brand identity.
Final e-voting results to be announced on or before June 9, 2026.
👀 What to Watch
Investors should view this consolidation positively as it streamlines the corporate structure and reduces administrative overhead. Monitor the official announcement of voting results on June 9 and subsequent NCLT final approval for completion timelines.
Meghmani Organics Shareholders Meet to Approve Merger of Two Subsidiaries
Meghmani Organics Limited (MOL) held an NCLT-convened meeting on June 6, 2026, to seek shareholder approval for the amalgamation of its wholly-owned subsidiaries, Kilburn Chemicals and Meghmani Crop Nutrition, into the parent company. The merger is intended to simplify the group structure, eliminate duplicate compliance costs, and achieve operational synergies. The meeting was conducted via video conferencing, and a special resolution was placed before the members. The final voting results are expected to be disclosed by June 9, 2026.
Key Highlights
Proposed amalgamation of Kilburn Chemicals and Meghmani Crop Nutrition with Meghmani Organics Limited.
NCLT-convened meeting held on June 6, 2026, to pass a special resolution for the scheme.
Strategic objective to create a single listed entity and optimize resource utilization.
Consolidation expected to reduce administrative overheads and rationalise costs.
Voting results to be officially announced on or before June 9, 2026.
👀 What to Watch
This consolidation is a positive step toward corporate simplification and cost efficiency. Investors should monitor the official voting results and subsequent NCLT final orders to confirm the completion of the merger.
